Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial (Q81658198)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 July 2008

Language	Label	Description	Also known as
English	Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial	scientific article published on 16 July 2008

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Paul Emery

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Ferdinand C Breedveld

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Stephen Hall

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Patrick Durez

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

David J Chang

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Deborah Robertson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Amitabh Singh

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Ronald D Pedersen

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Andrew S Koenig

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Bruce Freundlich

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

16 July 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

372

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

375-382

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

9636

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional disability in rheumatoid arthritis patients compared with a community population in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early rheumatoid arthritis: time to aim for remission?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early rheumatoid arthritis: strategies for prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Stanford Health Assessment Questionnaire: dimensions and practical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961000-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)61000-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18635256%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81658198&oldid=1754522787"